The DOI matches its Crossref record; 592 of the 592 references it cites were found in a registry or an index.
NF-κB in biology and targeted therapy: new insights and translational implications
Open accessAbstract
NF-κB signaling has been discovered for nearly 40 years. Initially, NF-κB signaling was identified as a pivotal pathway in mediating inflammatory responses. However, with extensive and in-depth investigations, researchers have discovered that its role can be expanded to a variety of signaling mechanisms, biological processes, human diseases, and treatment options. In this review, we first scrutinize the research process of NF-κB signaling, and summarize the composition, activation, and regulatory mechanism of NF-κB signaling. We investigate the interaction of NF-κB signaling with other important pathways, including PI3K/AKT, MAPK, JAK-STAT, TGF-β, Wnt, Notch, Hedgehog, and TLR signaling. The physiological and pathological states of NF-κB signaling, as well as its intricate involvement in inflammation, immune regulation, and tumor microenvironment, are also explicated. Additionally, we illustrate how NF-κB signaling is involved in a variety of human diseases, including cancers, inflammatory and autoimmune diseases, cardiovascular diseases, metabolic diseases, neurological diseases, and COVID-19. Further, we discuss the therapeutic approaches targeting NF-κB signaling, including IKK inhibitors, monoclonal antibodies, proteasome inhibitors, nuclear translocation inhibitors, DNA binding inhibitors, TKIs, non-coding RNAs, immunotherapy, and CAR-T. Finally, we provide an outlook for research in the field of NF-κB signaling. We hope to present a stereoscopic, comprehensive NF-κB signaling that will inform future research and clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 592
Makarov, S. S. (2001) · Arthritis Research · doi:10.1186/ar300 · Cited by 447
Determinants of dopaminergic neuron loss in Parkinson's disease
Surmeier, D. J. (2018) · The FEBS Journal · doi:10.1111/febs.14607 · Cited by 444
Sequential control of Toll-like receptor–dependent responses by IRAK1 and IRAK2
Kawagoe, T., Sato, S., Matsushita, K., Kato, H., Matsui, K., Kumagai, Y., Saitoh, T., Kawai, T., Takeuchi, O., & Akira, S. (2008) · Nature Immunology · doi:10.1038/ni.1606 · Cited by 442
Reilly, S. M., Chiang, S.-H., Decker, S. J., Chang, L., Uhm, M., Larsen, M. J., Rubin, J. R., Mowers, J., White, N. M., Hochberg, I., et al. (2013) · Nature Medicine · doi:10.1038/nm.3082 · Cited by 433
Niewczas, M. A., Pavkov, M. E., Skupien, J., Smiles, A., Md Dom, Z. I., Wilson, J. M., Park, J., Nair, V., Schlafly, A., Saulnier, P.-J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0415-5 · Cited by 432
Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols
Jin, Q., Liu, T., Qiao, Y., Liu, D., Yang, L., Mao, H., Ma, F., Wang, Y., Peng, L., & Zhan, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1185317 · Cited by 431
Zabel, U., & Baeuerle, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90806-p · Cited by 430
Macrophages at the interface of the co-evolving cancer ecosystem
Kloosterman, D. J., & Akkari, L. (2023) · Cell · doi:10.1016/j.cell.2023.02.020 · Cited by 427
Tacrolimus: A Further Update of its Use in the Management of Organ Transplantation
Scott, L. J., McKeage, K., Keam, S. J., & Plosker, G. L. (2003) · Drugs · doi:10.2165/00003495-200363120-00006 · Cited by 422
Regulation of NF-κB, Th Activation, and Autoinflammation by the Forkhead Transcription Factor Foxo3a
Lin, L., Hron, J. D., & Peng, S. L. (2004) · Immunity · doi:10.1016/j.immuni.2004.06.016 · Cited by 421
Tumor suppressor activity of the TGF-β pathway in human cancers
Markowitz, S. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/1359-6101(96)00001-9 · Cited by 416
Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I. R., Schwarz, E. M., Takeshita, S., Wagner, E. F., Noda, M., Matsuo, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610701200 · Cited by 408
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Crow, M. K. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223741 · Cited by 398
McLaren, J. E., Michael, D. R., Ashlin, T. G., & Ramji, D. P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.04.002 · Cited by 397
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2324 · Cited by 394
Moreau, P., Dimopoulos, M.-A., Mikhael, J., Yong, K., Capra, M., Facon, T., Hajek, R., Špička, I., Baker, R., Kim, K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00592-4 · Cited by 392
CARMA1, BCL-10 and MALT1 in lymphocyte development and activation
Thome, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1352 · Cited by 391 · cited 1×
“78, 79 PKC θ and PKC β mediate the interaction between TAK1 and CARMA1 and recruit IKK, which activates downstream NF-κ B signaling.”
BackgroundNF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
Celiac Disease and Nonceliac Gluten Sensitivity: A Review
Leonard, M. M., Sapone, A., Catassi, C., & Fasano, A. (2017) · JAMA · doi:10.1001/jama.2017.9730 · Cited by 391
Chen, X., Liu, G., Yuan, Y., Wu, G., Wang, S., & Yuan, L. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2157-1 · Cited by 388
Self-citationHenkel, T., Zabel, U., van Zee, K., Müller, J. M., Fanning, E., & Baeuerle, P. A. (1992) · Cell · doi:10.1016/0092-8674(92)90083-o · Cited by 385
NF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383
Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., & Saiki, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301598200 · Cited by 377
Huang, S., Robinson, J. B., DeGuzman, A., Bucana, C. D., & Fidler, I. J. (2000) · PubMed · Cited by 369
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
PPARs: diverse regulators in energy metabolism and metabolic diseases
Wang, Y.-X. (2010) · Cell Research · doi:10.1038/cr.2010.13 · Cited by 366
Shakibaei, M., John, T., Schulze-Tanzil, G., Lehmann, I., & Mobasheri, A. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.005 · Cited by 364
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Hideshima, T., Ikeda, H., Chauhan, D., Okawa, Y., Raje, N., Podar, K., Mitsiades, C., Munshi, N. C., Richardson, P. G., Carrasco, R. D., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199604 · Cited by 363
Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352
Targeting Th17 cells in autoimmune diseases
Yang, J., Sundrud, M. S., Skepner, J., & Yamagata, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.07.006 · Cited by 348
The Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice
Chiang, S.-H., Bazuine, M., Lumeng, C. N., Geletka, L. M., Mowers, J., White, N. M., Ma, J.-T., Zhou, J., Qi, N., Westcott, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.046 · Cited by 344
Dejardin, E. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.007 · Cited by 344
Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia
Vilimas, T., Mascarenhas, J., Palomero, T., Mandal, M., Buonamici, S., Meng, F., Thompson, B., Spaulding, C., Macaroun, S., Alegre, M.-L., et al. (2007) · Nature Medicine · doi:10.1038/nm1524 · Cited by 335
Sandborn, W. J., Present, D. H., Isaacs, K. L., Wolf, D. C., Greenberg, E., Hanauer, S. B., Feagan, B. G., Mayer, L., Johnson, T., Galanko, J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00877-1 · Cited by 333
Kiriakidou, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-01004 · Cited by 333
Parry, G. C., & Mackman, N. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5450 · Cited by 332
Gregersen, P. K., Amos, C. I., Lee, A. T., Lu, Y., Remmers, E. F., Kastner, D. L., Seldin, M. F., Criswell, L. A., Plenge, R. M., Holers, V. M., et al. (2009) · Nature Genetics · doi:10.1038/ng.395 · Cited by 332
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329
The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling
Ananieva, O., Darragh, J., Johansen, C., Carr, J. M., McIlrath, J., Park, J. M., Wingate, A., Monk, C. E., Toth, R., Santos, S. G., et al. (2008) · Nature Immunology · doi:10.1038/ni.1644 · Cited by 326
Luo, W., Weisel, F., & Shlomchik, M. J. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.008 · Cited by 325
Regulatory T cells in multiple sclerosis and myasthenia gravis
Danikowski, K. M., Jayaraman, S., & Prabhakar, B. S. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0892-8 · Cited by 323
NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro
Ward, C., Chilvers, E. R., Lawson, M. F., Pryde, J. G., Fujihara, S., Farrow, S. N., Haslett, C., & Rossi, A. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4309 · Cited by 320
Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy
Topalian, S. L., Forde, P. M., Emens, L. A., Yarchoan, M., Smith, K. N., & Pardoll, D. M. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.011 · Cited by 317 · cited 1×
“526,527 These agents act by blocking the PD-1/PD-L1 interaction, thereby releasing the brakes on the immune system and combating cancer immune evasion.”
BackgroundChauhan, D., Tian, Z., Zhou, B., Kuhn, D., Orlowski, R., Raje, N., Richardson, P., & Anderson, K. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0476 · Cited by 316
Chen, S., Ye, J., Chen, X., Shi, J., Wu, W., Lin, W., Lin, W., Li, Y., Fu, H., & Li, S. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1193-6 · Cited by 315
Self-citationThe Bcl-3 oncoprotein acts as a bridging factor between NF-κB/Rel and nuclear co-regulators
Dechend, R., Hirano, F., Lehmann, K., Heissmeyer, V., Ansieau, S., Wulczyn, F. G., Scheidereit, C., & Leutz, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202717 · Cited by 312
Notch1 augments NF‐κB activity by facilitating its nuclear retention
Shin, H. M., Minter, L. M., Cho, O. H., Gottipati, S., Fauq, A. H., Golde, T. E., Sonenshein, G. E., & Osborne, B. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600902 · Cited by 306
Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo
Nixon, C. C., Mavigner, M., Sampey, G. C., Brooks, A. D., Spagnuolo, R. A., Irlbeck, D. M., Mattingly, C., Ho, P. T., Schoof, N., Cammon, C. G., et al. (2020) · Nature · doi:10.1038/s41586-020-1951-3 · Cited by 299
NF-κB c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer
Grinberg-Bleyer, Y., Oh, H., Desrichard, A., Bhatt, D. M., Caron, R., Chan, T. A., Schmid, R. M., Klein, U., Hayden, M. S., & Ghosh, S. (2017) · Cell · doi:10.1016/j.cell.2017.08.004 · Cited by 297
Mechanisms of action of lenalidomide in B-cell non-Hodgkin lymphoma
Gribben, J. G., Fowler, N., & Morschhauser, F. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5363 · Cited by 296
Xiao, G., Fong, A., & Sun, S.-C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401428200 · Cited by 295
O'Connor, O. A., Stewart, A. K., Vallone, M., Molineaux, C. J., Kunkel, L. A., Gerecitano, J. F., & Orlowski, R. Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0822 · Cited by 295
Coats, B. R., Schoenfelt, K. Q., Barbosa-Lorenzi, V. C., Peris, E., Cui, C., Hoffman, A., Zhou, G., Fernandez, S., Zhai, L., Hall, B. A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.096 · Cited by 291
New insights into pre-BCR and BCR signalling with relevance to B cell malignancies
Rickert, R. C. (2013) · Nature Reviews Immunology · doi:10.1038/nri3487 · Cited by 288
Flow-induced reprogramming of endothelial cells in atherosclerosis
Tamargo, I. A., Baek, K. I., Kim, Y., Park, C., & Jo, H. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00883-1 · Cited by 286
CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different
Lork, M., Verhelst, K., & Beyaert, R. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.46 · Cited by 282
Ermolaeva, M. A., Michallet, M.-C., Papadopoulou, N., Utermöhlen, O., Kranidioti, K., Kollias, G., Tschopp, J., & Pasparakis, M. (2008) · Nature Immunology · doi:10.1038/ni.1638 · Cited by 281
The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis
Novack, D. V., Yin, L., Hagen-Stapleton, A., Schreiber, R. D., Goeddel, D. V., Ross, F. P., & Teitelbaum, S. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030116 · Cited by 281
Targeting Notch in oncology: the path forward
Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00091-3 · Cited by 270
IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family
Inoue, J.-I., Kerr, L. D., Kakizuka, A., & Verma, I. M. (1992) · Cell · doi:10.1016/0092-8674(92)90082-n · Cited by 269
Uhlenhaut, N. H., Barish, G. D., Yu, R. T., Downes, M., Karunasiri, M., Liddle, C., Schwalie, P., Hübner, N., & Evans, R. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.013 · Cited by 265
The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Espinosa, L., Cathelin, S., D'Altri, T., Trimarchi, T., Statnikov, A., Guiu, J., Rodilla, V., Inglés-Esteve, J., Nomdedeu, J., Bellosillo, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.006 · Cited by 265
Chen, K., Coonrod, E. M., Kumánovics, A., Franks, Z. F., Durtschi, J. D., Margraf, R. L., Wu, W., Heikal, N. M., Augustine, N. H., Ridge, P. G., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.009 · Cited by 261
Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
Adcock, I. M., Lane, S. J., Brown, C. R., Lee, T. H., & Barnes, P. J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.6.1951 · Cited by 261
Haberzettl, P., O’Toole, T. E., Bhatnagar, A., & Conklin, D. J. (2016) · Environmental Health Perspectives · doi:10.1289/ehp212 · Cited by 260
Pal, S. K., Uzzo, R., Karam, J. A., Master, V. A., Donskov, F., Suarez, C., Albiges, L., Rini, B., Tomita, Y., Kann, A. G., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01658-0 · Cited by 253
Hanker, A. B., Kaklamani, V., & Arteaga, C. L. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1175 · Cited by 251
Pone, E. J., Zhang, J., Mai, T., White, C. A., Li, G., Sakakura, J. K., Patel, P. J., Al-Qahtani, A., Zan, H., Xu, Z., et al. (2012) · Nature Communications · doi:10.1038/ncomms1769 · Cited by 250
Self-citationTBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue
Zhao, P., Wong, K. I., Sun, X., Reilly, S. M., Uhm, M., Liao, Z., Skorobogatko, Y., & Saltiel, A. R. (2018) · Cell · doi:10.1016/j.cell.2018.01.007 · Cited by 250
Gardam, S., Sierro, F., Basten, A., Mackay, F., & Brink, R. (2008) · Immunity · doi:10.1016/j.immuni.2008.01.009 · Cited by 248
The Th17 immune response is controlled by the Rel–RORγ–RORγT transcriptional axis
Ruan, Q., Kameswaran, V., Zhang, Y., Zheng, S., Sun, J., Wang, J., DeVirgiliis, J., Liou, H.-C., Beg, A. A., & Chen, Y. H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110462 · Cited by 248
Hedgehog signaling in tissue homeostasis, cancers and targeted therapies
Jing, J., Wu, Z., Wang, J., Luo, G., Lin, H., Fan, Y., & Zhou, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01559-5 · Cited by 247
Frati, G., Schirone, L., Chimenti, I., Yee, D., Biondi-Zoccai, G., Volpe, M., & Sciarretta, S. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx011 · Cited by 244
Sen, R., & Baltimore, D. (2006) · PubMed · Cited by 239
Nolan, G. P., Fujita, T., Bhatia, K., Huppi, C., Liou, H. C., Scott, M. L., & Baltimore, D. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3557 · Cited by 237
The Transcription Factor Nuclear Factor-kappa B and Cancer
Escárcega, R. O., Fuentes-Alexandro, S., García-Carrasco, M., Gatica, A., & Zamora, A. (2007) · Clinical Oncology · doi:10.1016/j.clon.2006.11.013 · Cited by 237
Hong, D. S., Kurzrock, R., Supko, J. G., He, X., Naing, A., Wheler, J., Lawrence, D., Eder, J. P., Meyer, C. J., Ferguson, D. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2703 · Cited by 236
Aggarwal, B. B. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i6 · Cited by 235
Nuclear Factor–κB and Its Role in Sepsis‐Associated Organ Failure
Abraham, E. (2003) · The Journal of Infectious Diseases · doi:10.1086/374750 · Cited by 234
NF-κB control of T cell development
Gerondakis, S., Fulford, T. S., Messina, N. L., & Grumont, R. J. (2014) · Nature Immunology · doi:10.1038/ni.2785 · Cited by 233
Lu, Q.-B., Wan, M.-Y., Wang, P.-Y., Zhang, C.-X., Xu, D.-Y., Liao, X., & Sun, H.-J. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.012 · Cited by 231
NF-κB modulators in osteolytic bone diseases
Xu, J., Wu, H. F., Ang, E. S. M., Yip, K., Woloszyn, M., Zheng, M. H., & Tan, R. X. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.007 · Cited by 229
Truax, A. D., Chen, L., Tam, J. W., Cheng, N., Guo, H., Koblansky, A. A., Chou, W.-C., Wilson, J. E., Brickey, W. J., Petrucelli, A., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.08.009 · Cited by 228
RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100
Solan, N. J., Miyoshi, H., Carmona, E. M., Bren, G. D., & Paya, C. V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109619200 · Cited by 224
Zhong, W., Wu, K., Long, Z., Zhou, X., Zhong, C., Wang, S., Lai, H., Guo, Y., Lv, D., Lu, J., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01289-w · Cited by 223
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Charabati, M., Wheeler, M. A., Weiner, H. L., & Quintana, F. J. (2023) · Cell · doi:10.1016/j.cell.2023.03.008 · Cited by 222
The role of cytokines in T‐cell memory in health and disease
Raeber, M. E., Zurbuchen, Y., Impellizzieri, D., & Boyman, O. (2018) · Immunological Reviews · doi:10.1111/imr.12644 · Cited by 221
Uncoupling the mechanisms of obesity and hypertension by targeting hypothalamic IKK-β and NF-κB
Purkayastha, S., Zhang, G., & Cai, D. (2011) · Nature Medicine · doi:10.1038/nm.2372 · Cited by 220
Heise, N., De Silva, N. S., Silva, K., Carette, A., Simonetti, G., Pasparakis, M., & Klein, U. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132613 · Cited by 220
Uric Acid Induces Renal Inflammation via Activating Tubular NF-κB Signaling Pathway
Zhou, Y., Fang, L., Jiang, L., Wen, P., Cao, H., He, W., Dai, C., & Yang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039738 · Cited by 219
Hyun, J., Wang, S., Kim, J., Rao, K. M., Park, S. Y., Chung, I., Ha, C.-S., Kim, S.-W., Yun, Y. H., & Jung, Y. (2016) · Nature Communications · doi:10.1038/ncomms10993 · Cited by 219
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
Abramson, S. B. (2002) · Rheumatology · doi:10.1093/rheumatology/41.9.972 · Cited by 217
Wang, R., Ma, Y., Zhan, S., Zhang, G., Cao, L., Zhang, X., Shi, T., & Chen, W. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2252-3 · Cited by 216
Transmembrane adaptor proteins: organizers of immunoreceptor signalling
Hořejší, V., Zhang, W., & Schraven, B. (2004) · Nature Reviews Immunology · doi:10.1038/nri1414 · Cited by 212
Breitkreutz, I., Raab, M. S., Vallet, S., Hideshima, T., Raje, N., Mitsiades, C., Chauhan, D., Okawa, Y., Munshi, N. C., Richardson, P. G., et al. (2008) · Leukemia · doi:10.1038/leu.2008.174 · Cited by 209
Ilchovska, D. (., & Barrow, D. M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102741 · Cited by 208
Yan, Y.-X., Shao, M.-J., Qi, Q., Xu, Y.-S., Yang, X.-Q., Zhu, F.-H., He, S.-J., He, P.-L., Feng, C.-L., Wu, Y.-W., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.185 · Cited by 207
Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality
Choi, H., Kim, Y., Mirzaaghasi, A., Heo, J., Kim, Y. N., Shin, J. H., Kim, S., Kim, N. H., Cho, E. S., In Yook, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz6980 · Cited by 203
TRAF‐Mediated TNFR‐Family Signaling
Ha, H., Han, D., & Choi, Y. (2009) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds87 · Cited by 201
Kortuem, K. M., & Stewart, A. K. (2013) · Blood · doi:10.1182/blood-2012-10-459883 · Cited by 200
Liu, H., Lo, C. R., & Czaja, M. J. (2002) · Hepatology · doi:10.1053/jhep.2002.32534 · Cited by 199
TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets
Song, L., Liu, L., Wu, Z., Li, Y., Ying, Z., Lin, C., Wu, J., Hu, B., Cheng, S.-Y., Li, M., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62339 · Cited by 199
ITAM-mediated Signaling by the T-Cell Antigen Receptor
Love, P. E., & Hayes, S. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002485 · Cited by 196
Cellular and molecular mechanisms of Hedgehog signalling
Zhang, Y., & Beachy, P. A. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00591-1 · Cited by 196
Dutta, D., Jana, M., Majumder, M., Mondal, S., Roy, A., & Pahan, K. (2021) · Nature Communications · doi:10.1038/s41467-021-25767-1 · Cited by 195
Park, K.-J., Krishnan, V., O’Malley, B. W., Yamamoto, Y., & Gaynor, R. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.006 · Cited by 193
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Chelko, S. P., Asimaki, A., Lowenthal, J., Bueno-Beti, C., Bedja, D., Scalco, A., Amat-Alarcon, N., Andersen, P., Judge, D. P., Tung, L., et al. (2019) · Circulation · doi:10.1161/circulationaha.119.040676 · Cited by 192
Escrivà, M., Peiró, S., Herranz, N., Villagrasa, P., Dave, N., Montserrat-Sentís, B., Murray, S. A., Francí, C., Gridley, T., Virtanen, I., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02061-07 · Cited by 191
Park, Y. C., Ye, H., Hsia, C., Segal, D., Rich, R. L., Liou, H.-C., Myszka, D. G., & Wu, H. (2000) · Cell · doi:10.1016/s0092-8674(00)80889-2 · Cited by 190
Lyn Tyrosine KinaseAccentuating the Positive and the Negative
XU, Y., HARDER, K., HUNTINGTON, N., HIBBS, M., & TARLINTON, D. (2005) · Immunity · doi:10.1016/s1074-7613(04)00381-4 · Cited by 188
The CD40–CD154 interaction in B cell–T cell liaisons
Bishop, G. A., & Hostager, B. S. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00024-8 · Cited by 188
Wang, L., Zhang, H., Rodriguez, S., Cao, L., Parish, J., Mumaw, C., Zollman, A., Kamoka, M. M., Mu, J., Chen, D. Z., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.021 · Cited by 186
IκBβ acts to inhibit and activate gene expression during the inflammatory response
Rao, P., Hayden, M. S., Long, M., Scott, M. L., West, A. P., Zhang, D., Oeckinghaus, A., Lynch, C., Hoffmann, A., Baltimore, D., et al. (2010) · Nature · doi:10.1038/nature09283 · Cited by 186
Developmental and Tumor Angiogenesis Requires the Mitochondria-Shaping Protein Opa1
Herkenne, S., Ek, O., Zamberlan, M., Pellattiero, A., Chergova, M., Chivite, I., Novotná, E., Rigoni, G., Fonseca, T. B., Samardzic, D., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.007 · Cited by 185
Fan, C., Li, Q., Ross, D., & Engelhardt, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206718200 · Cited by 183
The role of NF-κB in breast cancer initiation, growth, metastasis, and resistance to chemotherapy
Pavitra, E., Kancharla, J., Gupta, V. K., Prasad, K., Sung, J. Y., Kim, J., Tej, M. B., Choi, R., Lee, J.-H., Han, Y.-K., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114822 · Cited by 183
The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8428-8436.2001 · Cited by 182
Macrophage Proliferation Sustains Adipose Tissue Inflammation in Formerly Obese Mice
Zamarron, B. F., Mergian, T. A., Cho, K. W., Martinez-Santibañez, G., Luan, D., Singer, K., DelProposto, J. L., Geletka, L. M., Muir, L. A., & Lumeng, C. N.-K. (2016) · Diabetes · doi:10.2337/db16-0500 · Cited by 181
Aberrant glycosylation in IgA nephropathy (IgAN)
Coppo, R., & Amore, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.05407.x · Cited by 180
Croston, G. E., Cao, Z., & Goeddel, D. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16514 · Cited by 180
Inhibition of LTβR signalling activates WNT-induced regeneration in lung
Conlon, T. M., John-Schuster, G., Heide, D., Pfister, D., Lehmann, M., Hu, Y., Ertüz, Z., Lopez, M. A., Ansari, M., Strunz, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2882-8 · Cited by 179
Emerging immunotherapies in multiple myeloma
Shah, U. A., & Mailankody, S. (2020) · BMJ · doi:10.1136/bmj.m3176 · Cited by 178
Wu, Z., Nasab, E. M., Arora, P., & Athari, S. S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03337-3 · Cited by 176
Guan, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139067.83419.46 · Cited by 175
Chadban, S., & Atkins, R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66583-x · Cited by 173
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
Guire, C. M., Prinz, M., Beyaert, R., & Loo, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.001 · Cited by 172
Zhang, Y., Lu, Y., Ma, L., Cao, X., Xiao, J., Chen, J., Jiao, S., Gao, Y., Liu, C., Duan, Z., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.013 · Cited by 172
The role of TBK1 in cancer pathogenesis and anticancer immunity
Runde, A. P., Mack, R. M., Breslin, P., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02352-y · Cited by 172
Self-citationPPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
Ahmed, W., Ziouzenkova, O., Brown, J. D., Devchand, P. R., Francis, S. A., Kadakia, M., Kanda, T., Orasanu, G., Sharlach, M., Zandbergen, F. J., et al. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01825.x · Cited by 170
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells
Contoli, M., Ito, K., Padovani, A., Poletti, D., Marku, B., Edwards, M. R., Stanciu, L. A., Gnesini, G., Pastore, A., Spanevello, A., et al. (2015) · Allergy · doi:10.1111/all.12627 · Cited by 170
USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
Xiong, W., Gao, X., Zhang, T., Jiang, B., Hu, M.-M., Bu, X., Gao, Y., Zhang, L., Xiao, B.-L., He, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29401-6 · Cited by 169
Self-citationNF-κB dynamics determine the stimulus specificity of epigenomic reprogramming in macrophages
Cheng, Q. J., Ohta, S., Sheu, K. M., Spreafico, R., Adelaja, A., Taylor, B., & Hoffmann, A. (2021) · Science · doi:10.1126/science.abc0269 · Cited by 168
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Manik, M., & Singh, R. K. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27405 · Cited by 168
Activation of the IκB Kinases by RIP via IKKγ/NEMO-mediated Oligomerization
Poyet, J.-L., Srinivasula, S. M., Lin, J.-H., Fernandes-Alnemri, T., Yamaoka, S., Tsichlis, P. N., & Alnemri, E. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006643200 · Cited by 167
4-1BB enhancement of CAR T function requires NF-κB and TRAFs
Li, G., Boucher, J. C., Kotani, H., Park, K., Zhang, Y., Shrestha, B., Wang, X., Guan, L., Beatty, N. J., Abate‐Daga, D., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121322 · Cited by 167
Lee, S. M., Schulz, C., Prabhash, K., Kowalski, D., Szczesna, A., Han, B., Rittmeyer, A., Talbot, T., Vicente, D., Califano, R., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00774-2 · Cited by 167
PKCβ regulates BCR-mediated IKK activation by facilitating the interaction between TAK1 and CARMA1
Shinohara, H., Yasuda, T., Aiba, Y., Sanjo, H., Hamadate, M., Watarai, H., Sakurai, H., & Kurosaki, T. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051591 · Cited by 165
TRAF ‐Mediated TNFR ‐Family Signaling
Arron, J. R., Walsh, M. C., & Choi, Y. (2002) · Current Protocols in Immunology · doi:10.1002/0471142735.im1109ds51 · Cited by 164
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Di, K., Lloyd, G. K., Abraham, V. M., MacLaren, A., Burrows, F. J., Desjardins, A., Trikha, M., & Bota, D. A. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov299 · Cited by 164
Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes
Oral, E. A., Reilly, S. M., Gomez, A. V., Meral, R., Butz, L., Ajluni, N., Chenevert, T. L., Korytnaya, E., Neidert, A. H., Hench, R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.006 · Cited by 164
Wang, X., Liu, R., Qu, X., Yu, H., Chu, H., Zhang, Y., Zhu, W., Wu, X., Gao, H., Tao, B., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.007 · Cited by 164
NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism
Yao, Z., Xing, L., & Boyce, B. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38716 · Cited by 163
Lee, Y. S., Park, J. S., Kim, J. H., Jung, S. M., Lee, J. Y., Kim, S., & Park, S. H. (2011) · Nature Communications · doi:10.1038/ncomms1469 · Cited by 162
Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic
Shah, F., Logsdon, D. P., Messmann, R. A., Fehrenbacher, J. C., Fishel, M. L., & Kelley, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0023-0 · Cited by 162
Gehrke, N., Hövelmeyer, N., Waisman, A., Straub, B. K., Weinmann-Menke, J., Wörns, M. A., Galle, P. R., & Schattenberg, J. M. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.008 · Cited by 162
Liu, H., Zhang, J., Xu, X., Lu, S., Yang, D., Xie, C., Jia, M., Zhang, W., Jin, L., Wang, X., et al. (2021) · Theranostics · doi:10.7150/thno.49054 · Cited by 162
Self-citationLUBAC regulates NF‐κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO
Niu, J., Shi, Y., Iwaï, K., & Wu, Z.-H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.264 · Cited by 161
RelB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation
Vaira, S., Johnson, T., Hirbe, A. C., Alhawagri, M., Anwisye, I., Sammut, B., O'Neal, J., Zou, W., Weilbaecher, K. N., Faccio, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708576105 · Cited by 160
Shao, J., Fujiwara, T., Kadowaki, Y., Fukazawa, T., Waku, T., Itoshima, T., Yamatsuji, T., Nishizaki, M., Roth, J. A., & Tanaka, N. (2000) · Oncogene · doi:10.1038/sj.onc.1203383 · Cited by 160
TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils
Alagbala Ajibade, A., Wang, Q., Cui, J., Zou, J., Xia, X., Wang, M., Tong, Y., Hui, W., Liu, D., Su, B., et al. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.010 · Cited by 159
Periostin in inflammation and allergy
Izuhara, K., Nunomura, S., Nanri, Y., Ogawa, M., Ono, J., Mitamura, Y., & Yoshihara, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2648-0 · Cited by 159
Bushdid, P. B., Brantley, D. M., Yull, F. E., Blaeuer, G. L., Hoffman, L. H., Niswander, L., & Kerr, L. D. (1998) · Nature · doi:10.1038/33435 · Cited by 158
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
Chanan-Khan, A. A., Swaika, A., Paulus, A., Kumar, S. K., Mikhael, J. R., Rajkumar, S. V., Dispenzieri, A. A., & Lacy, M. Q. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.38 · Cited by 158
Yao, L., Zhu, Z., Wu, J., Zhang, Y., Zhang, H., Sun, X., Qian, C., Wang, B., Xie, L., Zhang, S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900363r · Cited by 158
Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action
Oh, K., Patel, H., Gottschalk, R. A., Lee, W. S., Baek, S., Fraser, I. D. C., Hager, G. L., & Sung, M. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.012 · Cited by 157
STAT3 promotes IFNγ/TNFα‐induced muscle wasting in an NF‐κB‐dependent and IL‐6‐independent manner
Ma, J. F., Sánchez, B. J., Hall, D. T., Tremblay, A. K., Marco, S. D., & Gallouzi, I. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607052 · Cited by 156
The Effect of Sodium Salicylate and Aspirin on NF-κB
Frantz, B., & O’Neill, E. A. (1995) · Science · doi:10.1126/science.270.5244.2017 · Cited by 153
Characterization of the IκB-kinase NEMO Binding Domain
May, M. J., Marienfeld, R. B., & Ghosh, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206494200 · Cited by 152
Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model
Xia, Y., Yeddula, N., Leblanc, M., Ke, E., Zhang, Y., Oldfield, E., Shaw, R. J., & Verma, I. M. (2012) · Nature Cell Biology · doi:10.1038/ncb2428 · Cited by 152
Roles and functions of SARS-CoV-2 proteins in host immune evasion
Rashid, F., Xie, Z., Suleman, M., Shah, A., Khan, S., & Luo, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.940756 · Cited by 152
Mantsounga, C., Lee, C. F., Neverson, J., Sharma, S., Healy, A. L., Berus, J. M., Parry, C., Ceneri, N. M., López‐Giráldez, F., Chun, H. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110309 · Cited by 151
Eyre, R., Alférez, D., Santiago-Gómez, A., Spence, K., McConnell, J. C., Hart, C. A., Simões, B. M., Lefley, D. V., Tulotta, C., Storer, J. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12807-0 · Cited by 150
Goes, A. T. R., Jessé, C. R., Antunes, M. S., Ladd, F. V. L., Ladd, A. A. B. L., Luchese, C., Paroul, N., & Boeira, S. P. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.10.019 · Cited by 148
Malhotra, S., Costa, C., Eixarch, H., Keller, C. W., Amann, L., Martínez‐Banaclocha, H., Midaglia, L. S., Sarró, E., Machín-Díaz, I., Villar, L. M., et al. (2020) · Brain · doi:10.1093/brain/awaa084 · Cited by 148
Stat3 activation of NF-κB p100 processing involves CBP/p300-mediated acetylation
Nadiminty, N., Lou, W., Lee, S. O., Lin, X., Trump, D. L., & Gao, A. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509808103 · Cited by 147
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Noort, A. R., Tak, P. P., & Tas, S. W. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0527-3 · Cited by 146
Hong, S., Lim, S., Li, A. G., Lee, C., Lee, Y. S., Lee, E., Park, S. H., Wang, X., & Kim, S. (2007) · Nature Immunology · doi:10.1038/ni1451 · Cited by 146
Reiß, M. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00251-8 · Cited by 146
Paul, J., Soujon, M., Wengner, A. M., Zitzmann-Kolbe, S., Sturz, A., Haike, K., Keng Magdalene, K. H., Tan, S. H., Lange, M., Tan, S. Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.003 · Cited by 146
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
Brightbill, H. D., Suto, E., Blaquière, N., Ramamoorthi, N., Sujatha-Bhaskar, S., Gogol, E. B., Castanedo, G. M., Jackson, B. T., Kwon, Y. C., Haller, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02672-0 · Cited by 141
Mutual regulation of metabolic processes and proinflammatory NF-κB signaling
Kracht, M., Müller‐Ladner, U., & Schmitz, M. L. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.027 · Cited by 141
Obesity accelerates hair thinning by stem cell-centric converging mechanisms
Morinaga, H., Mohri, Y., Grachtchouk, M. A., Asakawa, K., Matsumura, H., Oshima, M., Takayama, N., Kato, T., Nishimori, Y., Sorimachi, Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03624-x · Cited by 140
Peng, Z.-P., Jiang, Z.-Z., Guo, H.-F., Zhou, M., Huang, Y., Ning, W.-R., Huang, J., Zheng, L., & Wu, Y. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.05.004 · Cited by 139
Chronic inhibition of nuclear factor-κB attenuates renal injury in the 5/6 renal ablation model
Fujihara, C. K., Antunes, G. R., Mattar, A. L., Malheiros, D. M. A. C., Vieira, J. M., & Zatz, R. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00184.2006 · Cited by 138
Cancer therapies based on targeted protein degradation — lessons learned with lenalidomide
Jan, M., Sperling, A. S., & Ebert, B. L. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00479-z · Cited by 137
Liang, S., Chen, Z., Jiang, G., Zhou, Y., Liu, Q., Su, Q., Wei, W., Du, J., & Wang, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.003 · Cited by 137
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
Shin, E. M., Hay, H. S., Lee, M. H., Goh, J. N., Tan, T. Z., Sen, Y. P., Lim, S. W., Yousef, E. M., Ong, H. T., Thike, A. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73451 · Cited by 134
Lin, Y.-C., Shun, C., Wu, M., & Chen, C. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1393 · Cited by 134
Huh, J. Y., Reilly, S. M., Abu-Odeh, M., Murphy, A. N., Mahata, S. K., Zhang, J., Cho, Y., Seo, J. B., Hung, C., Green, C. R., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.010 · Cited by 130
Self-citationHassanzadeh, K., & Rahimmi, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26865 · Cited by 129
Liu, X., Tang, R., Xu, J., Tan, Z., Liang, C., Meng, Q., Lei, Y., Hua, J., Zhang, Y., Liu, J., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-329349 · Cited by 129
Lipid Metabolism in Macrophages: Focus on Atherosclerosis
Sukhorukov, V. N., Khotina, V. A., Chegodaev, Y. S., Ivanova, E. A., Sobenin, I. A., & Orekhov, A. N. (2020) · Biomedicines · doi:10.3390/biomedicines8080262 · Cited by 128
Qureshi, R., Picon-Ruiz, M., Aurrekoetxea-Rodriguez, I., Nunes de Paiva, V., D’Amico, M., Yoon, H., Radhakrishnan, R., Morata-Tarifa, C., Ince, T., Lippman, M. E., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.008 · Cited by 127
Wang, N., Zhang, X., Ma, Z., Niu, J., Ma, S.-H., Wenjie, W., & Chen, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109729 · Cited by 127
Guo, L., & Tabrizchi, R. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.009 · Cited by 126
Current Trends of Renal Impairment in Multiple Myeloma
Yadav, P., Cook, M. A., & Cockwell, P. (2015) · Kidney Diseases · doi:10.1159/000442511 · Cited by 125
p53-dependent regulation of mitochondrial energy production by the RelA subunit of NF-κB
Johnson, R. F., Witzel, I.-I., & Perkins, N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4252 · Cited by 124
NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity
Gu, M., Zhou, X., Sohn, J. H., Zhu, L., Jie, Z., Yang, J., Zheng, X., Xie, X., Yang, J., Shi, Y., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00829-6 · Cited by 124
Jobin, C., Hellerbrand, C., Licato, L. L., Brenner, D. A., & Sartor, R. B. (1998) · Gut · doi:10.1136/gut.42.6.779 · Cited by 123
The impact of NF-κB signaling on pathogenesis and current treatment strategies in multiple myeloma
Vrábel, D., Pour, L., & Ševčíková, S. (2019) · Blood Reviews · doi:10.1016/j.blre.2018.11.003 · Cited by 123
Zhang, T., Ding, C., Chen, H., Zhao, J., Chen, Z., Chen, B., Mao, K., Hao, Y., Roulis, M., Xu, H. Y., et al. (2022) · Science Advances · doi:10.1126/sciadv.abl5723 · Cited by 122
c-Rel is a myeloid checkpoint for cancer immunotherapy
Li, T., Li, X., Zamani, A., Wang, W., Lee, C., Li, M., Luo, G., Eiler, E., Sun, H., Ghosh, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0061-3 · Cited by 120
Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation
Yu, J., Zhou, X., Chang, M., Nakaya, M., Chang, J.-H., Xiao, Y., William Lindsey, J., Dorta-Estremera, S., Cao, W., Zal, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7074 · Cited by 118
Rashidian, A., Muhammadnejad, A., Dehpour, A. R., Mehr, S. E., Akhavan, M. M., Shirkoohi, R., Chamanara, M., Mousavi, S. E., & Rezayat, S. M. (2016) · Inflammopharmacology · doi:10.1007/s10787-016-0263-6 · Cited by 117
Myocardin inhibits cellular proliferation by inhibiting NF-κB(p65)-dependent cell cycle progression
Tang, R., Zheng, X., Callis, T. E., Stansfield, W. E., He, J.-Y., Baldwin, A. S., Wang, D.-Z., & Selzman, C. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705842105 · Cited by 116
Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway
Liao, D., Zhong, L., Duan, T., Zhang, R.-H., Wang, X., Wang, G., Hu, K., Lv, X., & Kang, T. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0198 · Cited by 115
Tran, P. O. T., Gleason, C. E., & Robertson, R. P. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1772 · Cited by 114
Man, X., Piao, C., Lin, X., Kong, C., Cui, X., & Jiang, Y. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1262-4 · Cited by 113
Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation
Saito, T., Hasegawa, Y., Ishigaki, Y., Yamada, T., Gao, J., Imai, J., Uno, K., Kaneko, K., Ogihara, T., Shimosawa, T., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs298 · Cited by 112
Cited by
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
Lu, P., Ruan, D., Huang, M., Tian, M., Zhu, K., Gan, Z., & Xiao, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01852-x · Cited by 667
Pattern recognition receptors: function, regulation and therapeutic potential
Chen, R., Zou, J., Chen, J., Zhong, X., Kang, R., & Tang, D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02264-1 · Cited by 301
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Duan, Y., Xu, Y., Dou, Y., & Xu, D. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01654-2 · Cited by 300
The Role of Inflammation in Cancer: Mechanisms of Tumor Initiation, Progression, and Metastasis
Nishida, A., & Andoh, A. (2025) · Cells · doi:10.3390/cells14070488 · Cited by 270
Metadata
- Authors
- Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-03-04
- Volume
- 9
- Issue
- 1
- Pages
- 53-53
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4392343318
- Cited by
- 2,047
- References
- 592
- FWCI
- 313.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.